Abstract:Purpose: Xanthones demonstrated an array of pharmacological activities via non-covalent DNA interaction and have been widely utilized in new drug research. The introduction of the polar 1,2,3-triazole ring located at the C3-position of xanthone has not been reported thus far. Methods: In the present study, a series of xanthone derivatives were designed, synthesized, and characterized through H-1 NMR, C-13 NMR, and MS. The methyl thiazolyl tetrazolium method was used to evaluate the cytotoxic activity of compounds. Furthermore, the structure- activity relationship and the potential mechanism of target compounds were investigated. Results: The IC50 showed that the inhibitory activity of 18 target compounds was higher than that of the original xanthone intermediate 4. In particular, compound 1j was the most active agent against A549 cancer cells (IC50 = 32.4 + 2.2 mu M). Moreover, apoptosis analysis indicated different contributions of early/late apoptosis to cell death for compounds 1h and 1j. The results of Western blotting analysis showed that compound 1j significantly increased the expression of caspase 3, Box, and c-Jun N-terminal kinase, and regulated p53 to a better healthy state in cancer cells. Conclusion: We synthesized several derivatives of xanthone and evaluated their cytotoxicity. The evidence suggested that compound lj possessed greater anticancer potential for further evaluations.

Synthesis of Novel Pyrazole Carboxamide Derivatives and Discovery of Modulators for Apoptosis or Autophagy in A549 Lung Cancer Cells

Synthesis of Novel Oxime-Containing Pyrazole Derivatives and Discovery of Regulators for Apoptosis and Autophagy in A549 Lung Cancer Cells

Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells.

Synthesis and preliminary biological evaluation of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives as potential agents against A549 lung cancer cells.

Synthesis and discovery of autophagy inducers for A549 and H460 lung cancer cells, novel 1-(2'-hydroxy-3'-aroxypropyl)-3-aryl-1H-pyrazole-5-carbohydrazide derivatives.

Synthesis of Pyrazole Peptidomimetics and Their Inhibition Against A549 Lung Cancer Cells

Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives

Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells.

5-Alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives inhibit growth of lung cancer A549 cell by inducing apoptosis.

Biological Activities of Novel Pyrazolyl Hydroxamic Acid Derivatives Against Human Lung Cancer Cell Line A549.

Synthesis of 5-Benzyl-2-phenylpyrazolo[1,5-a]pyrazin-4,6(5H,7H)-dione Derivatives and Discovery of an Apoptosis Inducer for H322 Lung Cancer Cells.

Discovery of New Fluorescent Thiazole–pyrazoline Derivatives As Autophagy Inducers by Inhibiting Mtor Activity in A549 Human Lung Cancer Cells

Synthesis and Structure-Activity Relationships of Novel 1-Arylmethyl-3-aryl-1h-pyrazole-5-carbohydrazide Hydrazone Derivatives As Potential Agents Against A549 Lung Cancer Cells

Synthesis of 6-Cinnamoyl-2h-benzo[b][1,4]oxazin-3(4h)-ones and Their Effects on A549 Lung Cancer Cell Growth.

Novel 2-Amino-1,4-Naphthoquinone Derivatives Induce A549 Cell Death through Autophagy

Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells

Microwave-assisted synthesis, crystal structure of pyrazolo[1,5-a]pyrazin-4(5H)-ones and their selective effects on lung cancer cells.

Synthesis of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives and their inhibition against growth of A549 and H322 lung cancer cells.

Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2'-hydroxy-3'-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate.

A Novel Fluorinated Thiosemicarbazone Derivative- 2-(3,4-difluorobenzylidene) Hydrazinecarbothioamide Induces Apoptosis in Human A549 Lung Cancer Cells Via ROS-mediated Mitochondria-Dependent Pathway.